cigna tirzepatide coverage is ending employee for GLP-1 weight-loss drugs like Wegovy and Zepbound starting July 1. The decision highlights growing debates around cost, access, and the future of obesity treatment. #Cigna #GLP1 # Does UnitedHealthcare cover tirzepatide? Complete

According to Eli Lilly, the most common side effects of Zepbound (tirzepatide) are: Constipation Decreased appetite Diarrhea Fatigue Hair loss Heartburn and belching Indigestion Injection site reactions Nausea Stomach pain Vomiting In studies, most reactions like nausea, vomiting, and diarrhea occurred when people increased their dose but the effects generally decreased over time

It's not cheating - it's being strategic about meeting your body's needs when your appetite is suppressed

A: GLP-1 agonist therapy is suitable for individuals struggling with obesity or those who have not achieved significant weight loss through diet and exercise alone

I will stay with it and hopefully get to my goal

Smaller meals and slower eating may help reduce nausea, fullness, and stomach discomfort

People included in the analysis all had records of obesity and did not have diabetes, which itself can cause gastroparesis